{
  "report_rows": [
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.74 vs. cons $1.66",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$23.08B vs. cons $22.87B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Raytheon adjusted operating profit",
      "prediction": "BEAT",
      "answer": "pred ~$925M vs. cons $910M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS guidance midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$6.95 vs. cons $6.94 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted sales guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$94.00B vs. cons $94.08B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free cash flow guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.50B vs. cons $8.60B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.6,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "Day-5 residual ~+0.5% vs. day-1 residual ~+1.6%: the EPS beat and Raytheon execution support the initial move, but a FY2026 sales guide near ~$94.00B versus ~$94.08B consensus and unchanged ~$8.50B free-cash-flow guidance versus ~$8.60B consensus limit out-period estimate revisions.",
  "day5_confidence": "LOW"
}